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Abstract
Background: Obesity and short sleep duration are significant public health issues. Current evidence suggests that these conditions
are associated with cardiovascular disease, metabolic syndrome, inflammation, and premature mortality. Increased interest in the
potential link between obesity and short sleep duration, and its health consequences, has been driven by the apparent parallel
increase in the prevalence of both conditions in recent decades, their overlapping association with cardiometabolic outcomes,
and the potential causal connection between the two health issues. The SLUMBRx (Short Sleep Undermines Cardiometabolic
Health) study seeks to contribute to the development of a comprehensive adiposity-sleep model while laying the groundwork for
a future research program that will be designed to prevent and treat adiposity- and sleep-related cardiometabolic disease risk
factors.
Objective: This SLUMBRx study aims to address 4 topics pertinent to the adiposity-sleep hypothesis: the relationship between
adiposity and sleep duration; sex-based differences in the relationship between adiposity and sleep duration; the influence of
adiposity indices and sleep duration on cardiometabolic outcomes; and the role of socioecological factors as effect modifiers in
the relationship between adiposity indices, sleep, and cardiometabolic outcomes.
Methods: SLUMBRx will employ a large-scale survey (n=1000), recruiting 159 participants (53 normal weight, 53 overweight,
and 53 obese) to be assessed in 2 phases.
Results: SLUMBRx was funded by the National Institutes of Health, Heart, Lung, and Blood Institute through a K01 grant
award mechanism (1K01HL145128-01A1) on July 23, 2019. Institutional Review Board (IRB) approval for the research project
was sought and obtained on July 10, 2019. Phase 1 of SLUMBRx, the laboratory-based component of the study, will gather
objective adiposity indices (air displacement plethysmography and anthropometrics) and cardiometabolic data (blood pressure,
pulse wave velocity and pulse wave analysis, and a blood-based biomarker). Phase 2 of SLUMBRx, a 1-week, home-based
component of the study, will gather sleep-related data (home sleep testing or sleep apnea, actigraphy, and sleep diaries). During
phase 2, detailed demographic and socioecological data will be collected to contextualize hypothesized adiposity and
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sleep-associated cardiometabolic disease risk factors. Collection and analyses of these data will yield information necessary to
customize future observational and intervention research.
Conclusions: Precise implementation of the SLUMBRx protocol promises to provide objective and empirical data on the
interaction between body composition and sleep duration. The hypotheses that will be tested by SLUMBRx are important for
understanding the pathogenesis of cardiometabolic disease and for developing future public health interventions to prevent its
conception and treat its consequences.
International Registered Report Identifier (IRRID): PRR1-10.2196/27139
(JMIR Res Protoc 2021;10(3):e27139) doi: 10.2196/27139
KEYWORDS
abdominal obesity-metabolic syndrome; adiposity; body composition; body fat distribution; insufficient sleep syndrome;
observational study; short sleeper syndrome; sleep deprivation
Introduction
Background
Obesity and short sleep in adults are highly prevalent in the
United States [1]. Both conditions are associated with numerous
adverse health outcomes, including all-cause mortality [2],
cardiovascular disease [3], diabetes [4], metabolic syndrome
[5], inflammation [6], and psychiatric disorders [7].
Approximately 38% of adults in the United States are classified
as obese, with a BMI of 30 kg/m2 or greater [8]. Stratified by
sex, 35.2% of men and 40.5% of women meet the BMI cutoff
point for obesity [8]. Similarly, short sleep is common, with an
estimated 35.3% of adults in the United States receiving less
than the recommended 7 hours of sleep during a 24-hour period
[9]. Among this sample, 56.5% of men and 39.6% of women
self-reported snoring [9], a symptom associated with
sleep-disordered breathing [10]. Of increasing importance is
the relationship between short sleep, obesity, and
cardiometabolic outcomes [11,12]; nevertheless, little is known
about these associations [13] or how public health interventions
can be applied to prevent and treat adiposity and sleep-associated
cardiometabolic disease risk factors [14].
Although progress has been made in modeling the relationship
between sleep and adiposity, much work remains [15,16]. The
data from the epidemiological and experimental studies of
obesity and short sleep, although suggestive, need to be viewed
within context. Epidemiological studies frequently have several
methodological limitations, including being (1) retrospective,
(2) cross-sectional, and (3) based on self-reported data [17].
Often, (4) nonvalidated measures [9] are used along with (5)
inconsistent definitions of short sleep (eg, 6 [18] to 9 [19] hours).
In addition, such studies have (6) limited control over potential
confounding variables [20] and (7) report inconsistent modeling
of sleep as a cause or consequence of obesity [21]. Taken
together, these limitations often lead to mixed results. Moreover,
they limit the ability to evaluate causal models linking adiposity
and sleep duration, thereby precluding the capacity to posit
sleep as a modifiable risk factor for the treatment of overweight
and obesity.
Concurrently, experimental studies often rely on (1) small
sample sizes [22] combined with (2) terse periods of observation
[23] (3) in rigorously controlled settings (potentially eliciting
Hawthorne effects [24]), and (4) the suppression of one or more
free-living factors hypothesized to influence the relationship
between adiposity and sleep (eg, prohibiting exercise [25]).
Although experimental studies are methodologically rigorous
and suggestive of a causal connection between adiposity and
sleep, the design features often limit translation to free-living
populations.
The SLUMBRx (Short Sleep Undermines Cardiometabolic
Health) study will capitalize on the strengths of the literature
and attempt to address salient limitations. The methods and
findings from the epidemiological literature will be considered
by using a standardized survey approach to provide a theoretical
backdrop against which to contextualize results. The findings
and methods from the experimental literature will be
incorporated by collecting objective measures of adiposity,
sleep, and cardiometabolic outcomes. Therefore, the proposed
SLUMBRx research study can assist in filling important gaps
in our understanding of the relationship between these health
outcomes.
Overarching Aim of the Proposed Research
The overarching aim of the SLUMBRx study is to acquire a
more comprehensive understanding of the relationship among
adiposity, short sleep, and cardiometabolic risk factors (Table
1). The relationship between adiposity and sleep duration will
be investigated to facilitate the primary aim of the SLUMBRx
study. First, although studies have identified associations
between obesity and short sleep in adults, there are occasional
inconsistencies in research findings, with some studies observing
an inverse linear relationship, U-shaped association, or no
significant relationship [15,26,27]. Second, sex-based
differences in the relationship between adiposity and sleep will
be evaluated. Studies within this domain have identified
interesting, yet often, inconsistent findings [25,28-31]. However,
few studies have examined sex-based variations in adiposity
and sleep duration using rigorous measures of adiposity
[25,28-31]. Third, the association between adiposity and sleep
on cardiometabolic outcomes requires further investigation,
particularly considering updated blood pressure guidelines [32].
Fourth, adiposity, sleep, and cardiometabolic outcomes are
influenced by a myriad of upstream and downstream factors
[33]. Contextualizing the adiposity-sleep connection from a
socioecological perspective [34] is crucial to understanding the
full scope of their relationship and impact on cardiometabolic
disease.
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Table 1. Hypotheses and methods of analysis.
Method of analysisHypothesis
Analysis 1: continuous outcome sleep hours will be evaluated using a one-
way ANOVAa for BMI (3 levels: normal, overweight, and obese)
Hypothesis 1: participants who are overweight and obese will demonstrate
significantly shorter sleep relative to participants classified as normal
weight
Analysis 2: continuous outcome sleep hours will be evaluated using facto-
rial ANOVA. The interaction effects between sex (2 levels: male and fe-
male) and BMI (3 levels: normal, overweight, and obese) will be examined
Hypothesis 2: male and female participants will demonstrate significantly
different adiposity effects on sleep duration outcomes
Analysis 3: continuous cardiometabolic risk factors are dependent variables.
Sleep (2 levels: short and normal) and BMI (3 levels: normal, overweight,
and obese) are independent variables. Factorial ANOVA will be used to
evaluate the interaction effects as well as simple effects of sleep and obe-
sity on cardiometabolic risk factors
Hypothesis 3: participants who are overweight and obese will exhibit
greater cardiometabolic risk outcomes compared with those who are normal
weight; this relationship will be stronger in participants who are overweight
and obese with short sleep duration
Analysis 4: descriptive statistics will provide important information regard-
ing the impact of socioecological variables on sleep. Linear mixed models
will be used to examine multilevel effects. Sleep hours is the dependent
variable. Cardiometabolic (cardio), obesity, social, and societal factors
are the independent variables
Exploratory specific aim 4: to explore the role of socioecological factors
(societal, social, and individual levels) as effect modifiers in the relation-
ship between adiposity indices, sleep, and cardiometabolic outcomes. No
formal hypothesis testing will occur for specific aim 4, because of sample
size limitations
aANOVA: analysis of variance.
Specific Aims and Hypotheses
A community sample (N=160) of participants who are normal
weight, overweight, and obese will be invited to participate in
the proposed SLUMBRx study to accomplish these goals. Phase
1 of SLUMBRx will include measurement of adiposity indices
and cardiometabolic outcomes in a clinical setting. Phase 2 of
SLUMBRx will include sleep apnea screening and 1 week of
daily sleep diaries and actigraphy using epidemiological data
collection techniques. During phase 2, participants completed
a set of validated questionnaires examining sociodemographic
factors associated with adiposity indices, sleep disorders, and
cardiometabolic outcomes.
Objective measures of adiposity indices, sleep outcomes, and
cardiometabolic predictors will be collected from participants
over the course of the SLUMBRx study. Specific measures will
include the following:
• Adiposity indices: anthropometrics (BMI, skinfold
thicknesses, and circumferences) [35,36] and air
displacement plethysmography [37].
• Cardiometabolic predictors: blood pressure [38], pulse wave
velocity and pulse wave analysis [39,40], and blood-based
biomarkers [41].
• Sleep outcomes: home sleep testing or sleep apnea [42,43],
sleep diaries [44], and actigraphy [45].
In addition to clinical outcomes, sex-based differences in the
relationship between adiposity and sleep duration will be
investigated [25,28-31]. This study will also assess
socioecological factors [33] that influence adiposity indices,
sleep, and cardiometabolic outcomes as an exploratory aim.
• Specific aim 1: to determine the relationship between
adiposity and sleep duration.
• Hypothesis 1: participants who are overweight and
obese will demonstrate significantly shorter sleep than
participants classified as normal weight.
• Specific aim 2: to evaluate sex-based differences in the
relationship between adiposity and sleep duration.
• Hypothesis 2: male and female participants will
demonstrate significantly different adiposity effects on
sleep duration outcomes.
• Specific aim 3: to assess whether adiposity and sleep
duration influence cardiometabolic outcomes.
• Hypothesis 3: participants who are overweight and
obese will exhibit greater cardiometabolic risk
outcomes compared with participants who are of normal
weight; this relationship will be stronger in participants
who are overweight and obese with short sleep duration.
• Specific aim 4 (exploratory): to explore the role of
socioecological factors as effect modifiers in the relationship
between adiposity, sleep, and cardiometabolic outcomes.
• Owing to sample size limitations, formal hypothesis
testing will not occur for aim 4.
Methods
Sample Size Considerations
Power analyses for testing the SLUMBRx hypotheses were
calculated [46] using an αof .05 and effect sizes that would
yield a power of 0.80. Sample size estimates were primarily
based on detecting significance for specific aim 1. Data from
the 2007 to 2008 National Health and Nutrition Examination
Survey (NHANES) [47] were used to estimate the power
analysis parameters. Analysis of NHANES data revealed that
mean sleep hours were 7.08 (SD 1.3) hours for individuals who
are normal weight, 6.84 (SD 1.3) hours for individuals who are
overweight, and 6.72 (SD 1.3) hours for individuals who are
obese. Although NHANES data were based on self-reports, the
SLUMBRx study will apply validated sleep diaries and objective
sleep measures (accelerometers). Therefore, the means and SDs
for the proposed SLUMBRx study would likely be smaller than
those of NHANES. Applying an SD of 0.60 with the same mean
values of sleep duration as NHANES for the 3 groups, 53
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participants per group are required to achieve a power of 0.80,
with an effect size of 0.25 for a total sample size of 159
participants for specific aim 1. Similar sample sizes are required
for the remaining specific aims. For example, using the same
parameters, specific aim 2 requires a sample size of 52
participants per group (156 total) to detect significant adiposity
by sex interaction (0.26 effect size). A total of 160 participants
will be recruited to accommodate specific aims 1 to 3.
A power analysis was not conducted for exploratory specific
aim 4. Given that this is the first attempt at building a
socioecological model of sleep, limited information is available
to specify sample size parameters. Although formal hypothesis
testing will not be conducted for specific aim 4, it is expected
that the descriptive statistics and multilevel model will provide
important information regarding the impact of socioecological
variables on sleep. There has been a continuous call for the
inclusion of socioecological models in public health, as these
models can provide a more comprehensive context to understand
sleep [48].
Inclusion and Exclusion Criteria
Inclusion criteria will limit SLUMBRx study eligibility to (1)
adults, 18 years of age or older, (2) with reliable internet access,
email, and telephone, and (3) a commitment to completing all
study activities. Exclusion criteria for the SLUMBRx study are
described in Textbox 1.
Textbox 1. Exclusion criteria for the SLUMBRx (Short Sleep Undermines Cardiometabolic Health) study.
• Participants must be willing to commit to the SLUMBRx protocol, which includes air displacement plethysmography, pulse wave velocity and
analysis, collection of blood-based biomarkers, home sleep testing, and completion of questionnaires. Commitment will be assessed during the
informed consent process to help ensure compliance and reduce study dropout.
• Unstable medical or psychological distress will be assessed using the Systematic Assessment for Treatment Emergent Events [49,50] questionnaire
and the Kessler-6 Psychological Distress Scale [51] to help deter confoundment of lab-based assessments.
• Current medical interventions and medications will be assessed through self-report. Medical interventions via prescription medications (eg,
statins) and treatment devices (eg, continuous positive airway pressure therapy) may confound the relationship between adiposity, sleep, and
cardiometabolic disease. Similar approaches have been used in other research protocols [52].
• Evidence of substance abuse will be assessed by the CAGE (cut-annoyed-guilty-eye)-Adapted to Include Drugs [53] to help deter confoundment
of lab-based assessments
• Pregnancy will be assessed by self-report to help ensure the fetus is not exposed to the procedures involved with the study and ensure the
biopsychosocial changes that occur with pregnancy do not confound the lab-based assessments.
• Inadequate language comprehension will be assessed during the intake portion of the lab-based assessment to assure the quality of self-report
data, as all the measures are in English
• Lack of return addresses will be assessed through self-report by asking potential participants to provide their mailing address. Data collection
tools, such as sleep apnea home-testing kits, must be returned upon use. As such, a return mailing address is required.
• Self-report data will primarily be collected through the web-based data portal; therefore, reliable internet access is required. An email address
and phone number are required to communicate with patients if they have any questions about the study and schedule the study's lab-based
component.
• Underweight BMI will be assessed by calculating self-reported height and weight. Although underweight BMI is an important variable [54],
budgetary constraints will prevent studying this issue for this proposal.
• Long sleep, defined as habitual sleep greater than 9 out of 24 hours [55], will be assessed using item 4 from the Pittsburgh Sleep Quality Index
[56]. Long sleep is a proposed risk factor for obesity and cardiometabolic disease. However, long sleep likely interacts with obesity and
cardiometabolic disease through unique mechanisms [57]. These issues, combined with budgetary constraints, informed the decision to exclude
participants who are underweight from this study.
For screening purposes, BMI [35] will be calculated from
self-reported height or weight. Although BMI will be
recalculated in a clinical setting during phase 1 of this study, it
is anticipated that measurement error associated with
self-reported height and weight for BMI calculations will be
acceptable for screening and initial group allocation purposes
(normal weight, overweight, and obese). Demographic data will
also be collected (eg, sex, age, race, or ethnicity) along with a
request for a commitment to study completion. Filler items will
be included in the screening survey to rule out professional
participants. Consent will be obtained for the screening data.
Inclusion of Children, Minorities, and Women
Children will not be included in the SLUMBRx study. Although
childhood obesity and poor sleep in children are critical health
concerns [58], the aims of SLUMBRx pertain specifically to
adults. Risk factors for short sleep and obesity in children appear
to operate differently than those underlying adult obesity and
poor sleep [59]. Regarding minority enrollment, there will be
an equal opportunity for members of all ethnic and racial
backgrounds to participate in the SLUMBRx study. Study design
and recruitment are expected to ensure that minorities are well
represented. On the basis of the United States Census Bureau’s
2016 population estimates for Tuscaloosa [60], we expect our
sample to reflect the following racial and minority
representation: 65.1% White, 31.8% African American or Black,
1.5% Asian, 0.3% American Indian or Alaskan Native, and
0.1% Native Hawaiian or Pacific Islander. This area’s ethnic
distribution is 3.5% Hispanic or Latino and 62.1% White alone,
not Hispanic or Latino. Recruitment prioritizes a representative
minority sample for this metropolitan area. Minority inclusion
will be closely monitored during recruitment to ensure adequate
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representation. Prioritized recruitment of minority groups will
be utilized should all groups be underrepresented.
Specific aim 2 of the SLUMBRx study is particularly focused
on investigating sex-based differences in the relationship
between adiposity and sleep duration. Therefore, the inclusion
of women is paramount to the success of this proposal. Multiple
studies suggest that women are at higher risk for obesity from
short sleep than men [28,61,62]. Other studies have found that
men with short sleep are at greater risk for obesity than women
[25,29,30]. Ford et al [31] found that sleep duration was
associated with BMI; however, there was no evidence of a
statistical interaction by gender, race, or ethnicity.
Possible Risks and Benefits to Participants
Risks
The risk to participants is expected to be minimal, as there are
minimal risks associated with the completion of the web-based
screening survey. Participants will be informed that they may
withdraw from the SLUMBRx study at any time if they
experience discomfort. Regarding air displacement
plethysmography, mild discomfort because of the small
dimensions of the chamber is possible. Participants who
experience distress will be referred for appropriate treatment.
There is minimal risk associated with the pulse wave velocity
device as it is applied externally and is noninvasive. In terms
of the blood draw, infection, bruising, fainting, and a small
amount of bleeding are possible. As participants will be in a
fasted state, there are some associated health risks, including
dizziness, decreased alertness, and symptoms associated with
low blood sugar levels. A qualified phlebotomist will draw
blood following standard procedures. In the event that the
participants have an adverse reaction to any of the medical
procedures, the proximity of the clinical setting where
SLUMBRx will transpire to proximity to the local hospital will
permit rapid access to emergency response teams. Regarding
the home sleep testing kit, mild discomfort from wearing the
equipment is possible. To minimize risk, participants will be
given a demonstration regarding the setup of the device and
oral and illustrated instructions. In addition, a 24-hour contact
number to call for any problems will be provided. Similarly,
mild discomfort from wearing the blood pressure cuff is
possible. To help offset risk, arm circumference will be
measured to ensure an appropriate cuff size. There are minimal
risks associated with the completion of the web-based screening
survey. The primary risk pertains to confidentiality rather than
safety risks. All participants will be assigned a study ID. Study
ID numbers will be used in all documents for review, evaluation,
and analysis. No verbal or written information concerning
participants will be released without written consent from the
subject. Publication of all results will maintain participant
confidentiality. Only group data will be reported. Data will be
stored under double-locked conditions and made available only
to qualified staff working directly on the project.
Benefits
Participants may gain satisfaction knowing they contributed to
a scientific study that may someday result in better diagnostic
and treatment options for adiposity, sleep, and cardiometabolic
risk factors. Participants will undergo health screening related
to their body composition and sleep and be referred to a local
sleep clinic if they have any medical questions or concerns.
They will also be provided with a financial incentive and receive
free food and drink during the conclusion of the lab-based
portion of the study. All participants who complete the full study
will be paid US $100.00; payment will be prorated as follows:
US $40.00 for the lab-based component of the study (phase 1)
and US $40.00 for the home-based component of the study
(phase 2). A US $20.00 bonus will supplement the compensation
for participants that provide complete data. However, the




A community sample (N=160) of participants who are normal
weight, overweight, and obese living in the city of Tuscaloosa,
Alabama, will be invited to participate in the SLUMBRx study.
Strategies for directing potential participants to the study include
posting announcements to web-based classifiers, distribution
of informational flyers or brochures throughout the community,
including community centers (Tuscaloosa County Park and
Recreation Authority), and churches, ads in minority papers
(eg, Mobile Beacon and Alabama Citizen), and poster
advertisements on the city commuter system (Tuscaloosa Transit
Authority). Research study advertising networks established by
the University of Alabama Strategic Communications
department will also be used. Specific procedures will be
employed to maximize our outreach to minority communities
and aggregate an ethnically diverse and representative sample,
such as targeted advertising, posting in places that serve minority
populations, and working with local clergy. In addition to
standard advertisement strategies, the study will also be
advertised through the University of Alabama media and the
established research networking channels developed and fostered
by the University of Alabama Institute for Rural Health
Research. Each advertisement medium will direct respondents
to the main study page.
With these plans, modest recruitment targets, and the Tuscaloosa
community’s size (population 99,543), it is anticipated that
recruitment will be accomplished in a timely manner.
Census data [63] indicate that the crude prevalence of obesity
for Tuscaloosa is 41.4%. Panel 3 provides model-based
estimates of sleeping less than 7 hours among adults aged 18
years and older living in Tuscaloosa. Census data also indicate
that the crude prevalence of short sleep for Tuscaloosa is 46.1%.
Respondents will be able to access the main study page and
screening survey through a variety of entry points. For example,
flyers will have removable tabs that provide the study page
URL, which respondents may tear off and store on their personal
computer. In addition to listing the website URL, paper mediums
(eg, flyers) will include a quick response code, allowing
respondents to access the study’s welcome page using their
phone camera. The welcome page will provide a basic
orientation for the study. If the subject is interested in
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participating in the study, they will be directed to click on the
I agree button located at the bottom of the welcome screen. By
clicking I agree, respondents will be directed to read and
complete 2 informed consent documents, one related to the
study and the other related to the Health Insurance Portability
and Accountability Act (HIPAA). Once these are read, if the
respondent wishes to continue in the study, they must agree to
the stipulations of the study consent form and HIPAA documents
by clicking on I agree button located at the bottom of the page.
The informed consent documents will be protected by a content
validation algorithm, ensuring that participants cannot proceed
to the screening survey without first providing consent.
Completing the consent documents initiates the assignment of
a study ID, recording of the date and time, and administration
of the screening survey. The screening survey will also capture
general information such as the respondents’ names, mailing
addresses, phone numbers, email, and demographic information.
Screening
Eligibility for the SLUMBRx study will be determined by
screening with standardized scales and questionnaires. This
component of the study will allow for the profiling of
participants in a manner that is consistent with large-scale
surveys undertaken with epidemiological research. All potential
participants may respond to the screening survey. BMI will be
calculated using respondents’ self-reported height and weight,
calculated as weight/height2 (expressed as kg/m2) [8]. Although
BMI will be recalculated under controlled conditions during
phase 1 of the study, we anticipate measurement error associated
with self-reported height and weight for BMI calculations
acceptable for screening purposes. On the basis of BMI,
participants invited into the study will be (by self-report) of
normal weight (BMI 18.5 to <25.0), overweight (BMI 25.0 to
<30.0), or obese (BMI ≥30.0). For the purposes of this study,
participants categorized as underweight (BMI <18.5) will be
excluded from participating. Researchers have proposed
different mechanisms (eg, eating disorders [54]) may be
responsible for the sleep outcomes observed in this group. These
issues, combined with budgetary constraints, informed the
decision to exclude participants who are underweight from this
study.
Following the completion of the screening survey, responses
will be reviewed to determine eligibility for the SLUMBRx
study. Eligibility was determined using the inclusion or
exclusion criteria. As this study sought equivalent sample sizes
for the 3 groups being investigated (normal weight, overweight,
and obese), once a particular group has reached saturation
(determined by calculating BMI from self-reported height and
weight), respondents falling into a saturated group will be
ineligible to participate in the study. Respondents meeting the
study criteria will be contacted to establish a convenient date
or time for initiation of the study’s laboratory-based portion.
Participants will also be made a temporary parking pass to grant
them convenient access to the Nutrition and Metabolism
Research Lab.
Consent Process
Potential participants will be required to provide consent before
being given access to the screening survey (for survey data
only). The SLUMBRx study will also require a consenting
process. In this instance, informed consent will be obtained
before initiating the laboratory-based study. In phase 1,
participants will be given a copy of the consent form to read in
private and the opportunity to ask questions. They will be
informed that declining to participate will in no way interfere
with their relationship with the University of Alabama and that
participation is voluntary, and they may withdraw at any point.
The principal investigator (PI) will take every precaution to
ensure that prospective participants understand what is being
asked of them before signing the consent form. In addition to
the screening survey, no data will be collected without obtaining
informed, signed, written consent.
Data Storage, Confidentiality, and Privacy
Every effort will be made to ensure participant privacy. Data
safety and monitoring will be evaluated by a data and safety
monitoring board. Whenever feasible, identifiers are removed
from the study-related information. All blood samples will be
identified by a barcode generated by a computer in place of
identifiable information. Data obtained for the proposed study
will be used only for this research project. A review of informed
consent documents for phases 1 and 2 of the SLUMBRx study
will occur face-to-face with participants behind closed doors in
a private interview room located within the Nutrition and
Metabolism Research Lab. Lab-based data will be collected in
patient rooms (behind closed doors with no windows in the
room) located within the Nutrition and Metabolism Research
Lab. All paper records will be kept in locked filing cabinets
located within the PI’s locked office (doubly locked) and will
only be accessible to personnel involved in the study. All
electronic records will be stored at the University of Alabama’s
password-protected HIPAA-compliant cloud service. Access
to the cloud requires a password and confirmation from a second
device using the Duo security platform. For example, when
attempting to log on to the cloud, not only must the PI enter the
correct password, but a confirmation of entry is sent to the PI’s
mobile device for confirmation of access. The password to the
cloud will frequently change as an additional form of data
protection. All interactions, including phone calls and emails,
to and from participants will comply with HIPAA regulations.
Data Collection
Following a web-based screening survey of participants,
qualified, consenting respondents will participate in a 2-phase
SLUMBRx study. Phase 1 entails the collection of objective
measures of adiposity and cardiometabolic outcomes. Phase 2
involves collecting subjective and objective sleep data using
sleep diaries, actigraphy, and home sleep testing for sleep apnea.
During phase 2, participants will also complete a battery of
validated questionnaires and scales assessing socioecological
factors associated with sleep, adiposity, and cardiometabolic
outcomes.
Phase 1: Laboratory-Based Study
This component of the SLUMBRx study will allow for objective
measures under controlled conditions typical of lab-based
studies. Participants will be escorted to the Nutrition and
Metabolism Research Lab, where they will review the study
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protocol and sign an informed consent form. Next, participants
will undergo a battery of tests related to the measurement of
adiposity and cardiometabolic indices outlined below.
Air-Displacement Plethysmography
The adult air-displacement plethysmography system,
commercially produced under the trade name BOD POD
(COSMED), has been validated [64,65] in adult populations
and is considered robust for the measurement of human body
composition [66,67]. Air-displacement plethysmography is a
whole-body densitometric technique based on the displacement
of air rather than water; it evaluates human body volume, body
density, and body composition by measuring air displacement
and the subsequent determination of body volume through the
application of Boyle law. The air-displacement plethysmography
unit consists of a dual-chamber plethysmograph, an electronic
scale, and a computer. This equipment has a single structure
containing 2 chambers separated by a device that produces
pressure fluctuations and volume changes, permitting body
volume assessment; this is followed by two to three 50-second
measurements with the subject in the BOD POD using estimated
thoracic lung volume to determine the fat mass, fat-free mass,
and percentage body fat (%BF).
Anthropometrics
All measurements will adhere to standardized protocols, and
anthropometric measures will all be performed by the same
trained clinician. BMI will be calculated as body weight (in
kilograms) without shoes and with light clothing, divided by
height (in meters) squared—expressed as kg/m2). Body weight
will be measured to 0.05 kg using the BOD POD electronic
scale. Height will be measured to the nearest 1 mm using a
stadiometer (Seca). For both height and weight, 2 measurements
will be obtained and averaged; a third measurement will be
obtained if the first two are more than 0.5 cm/0.1 kg apart and
then averaged. Skinfold thicknesses will be measured to the
nearest 0.1 mm with a skinfold caliper at the following sites
using the same averaging protocol: (1) triceps, halfway between
the acromion process and the olecranon process; (2) biceps, at
the same level as the triceps skinfold, directly above the center
of the cubital fossa; (3) subscapular, 20 mm below the tip of
the scapula, at an angle of 45° to the lateral side of the body;
and (4) suprailiac, 20 mm above the iliac crest and 20 mm
toward the medial line. Circumferences will be measured with
a nonelastic tape within 1 mm as follows: (1) waist
circumference will be measured at the end of a gentle expiration
midway between the lowest rib and iliac crest and (2) hips will
be measured at the greater trochanter. In addition to standard
circumference data, neck circumference will be measured
because of its correlation with cardiometabolic risk [68] and
sleep apnea in short sleepers [69]. Therefore, (3) neck
circumference will be measured in the midway of the neck
between the midcervical spine and midanterior neck. All
skinfold and circumference measures will be taken with the
participants standing upright, with the face directed toward the
clinician, and shoulders relaxed.
Pulse Wave Velocity and Pulse Wave Analysis
Arterial stiffness will be assessed by radial artery applanation
tonometry recording (Mobil-O-Graph [70]). Pulse wave analysis
is a noninvasive, valid, reliable, and inexpensive technique that
offers significant clinical and epidemiological potential. Briefly,
pressure is applied to the radial artery by a probe placed on the
wrist. The radial wave created by the signal is used to generate
an aortic pulse pressure waveform, which is used to derive an
augmentation index (AIx). AIx is an indication of arterial
stiffness, with a higher AIx signifying greater arterial stiffness
[39,40].
Blood Pressure
Hypertension has been proposed as an intermediate step in the
causal pathway between decreased sleep duration and
cardiovascular disease [57]. During the same visit, 2 systolic
and diastolic blood pressure readings will be recorded
(Mobil-O-Graph [71]) with a 5-minute interval and averaged
for analysis. A third measurement will be obtained if the
difference between the first two is >5 mm Hg [72]. Both blood
pressure and pulse wave velocity or pulse wave analysis will
be measured in a seated position after a 10-minute rest period
in a quiet room.
Cardiometabolic Biomarkers
Sleep duration is hypothesized to influence cardiometabolic
biomarkers [73]. Hyperlipidemia is an established risk factor
for cardiovascular disease [74] and may be linked to short sleep
[41]. Blood samples will be collected by a trained phlebotomist
in the Nutrition and Metabolism Research Lab for measures of
cholesterol (lipid panel with low-density lipoprotein:high-density
lipoprotein ratio) and glucose [52]. Samples will be taken in a
sitting position, centrifuged immediately, and transferred under
cold chain conditions to a central laboratory for analysis.
Phase 2: Prospective Assessment
This component of the SLUMBRx study will allow for the
sampling of adiposity, sleep, and cardiometabolic outcomes in
a manner consistent with naturalistic or ambulatory studies.
Home Sleep Testing
During their visit to the Nutrition and Metabolism Research
Lab, participants will be provided with a home sleep recording
device that will be used to screen for sleep apnea by recording
airflow, respiratory effort, and oxygen saturation. Participants
will be instructed on the device’s use and will be given a prepaid
envelope to return the device. All recordings will be scored by
trained technicians at the Alabama Neurology and Sleep
Medicine. Participants with an apnea-hypopnea index of ≥5 will
be referred for treatment [75].
Actigraphy and Questionnaires
Participants will complete a battery of questionnaires through
a web-based data portal. Questionnaires will include the Sleep
Timing Questionnaire (STQ) for habitual sleep schedule [76],
the Epworth Sleepiness Scale (ESS) for subjective sleepiness
[77], and the Pittsburgh Sleep Quality Index (PSQI) [56] for
sleep quality. Participants will also complete sleep diaries [44]
and wear an accelerometer for 1 week to provide an objective
assessment of sleep, following the guidelines by Ancoli-Israel
et al [78,79]. These assessments will be used to corroborate the
retrospective measures of sleep duration. In addition, previously
validated questionnaires and scales representing salient levels
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of the socioecological model of sleep (societal, social, and
individual) developed by Grandner et al [12,33] will be
completed by participants. Examples of questionnaires include
societal level [80,81] (Barriers to Care Questionnaire [82]),
social level [83,84] (Job Satisfaction Survey [84]), and
individual level [85,86] (Healthy Literacy Questionnaire [87],
Self-Efficacy for Sleep Scale [88], and demographics such as
education, marital status, annual household income, etc).
Potential Problems and Alternatives
If web-based data collection presents a significant barrier,
especially as it pertains to the recruitment of women and/or
minorities, paper-and-pencil versions of the data collection
materials will be provided to respondents. An alert system will
be incorporated into the web-based data portal to assist with
compliance, alerting study staff if a questionnaire or diary entry
has been missed. In addition, participants will be provided a
24/7 contact number and directions that will be tested for
readability. Budgetary allowances for 10 additional participants
(6.25%) were allocated as safeguards against attrition. Records
of respondents’ baseline characteristics will determine whether
differences between those that participate and those that do not
participate will be retained. If differences are identified,
statistical adjustments will be made to account for possible
selection bias. If violations to model assumptions are detected,
problematic data will be inspected. If possible, model
modifications (eg, transformation) will be made, rather than
dropping cases. The risks involved in this study are minimal.
Protocols will be enacted to manage potential risks.
Data Analytic Strategy and Analysis
Data Collection and Management
Most of the self-report data will be collected via a web-based
portal (Qualtrics LLC) dedicated to the proposed study. Data
from other sources will be entered into the same system by
trained research staff. When the data are fully aggregated, they
will be downloaded, screened, and summarized. A final analysis
database will be constructed with all summary variables
deidentified according to standardized confidentiality
procedures.
Data Analysis Plan
The primary study variables for the SLUMBRx study include
(1) sleep hours, (2) systolic blood pressure, (3) diastolic blood
pressure, (4) apnea-hypopnea index, (5) augmentation index,
(6) total lipid levels, and (7) glucose. It is hypothesized that,
relative to participants who are normal weight, those who are
overweight and obese will have differences in the distribution
of the primary study variables reflected either in mean changes
and/or increased variance. The primary study hypotheses will
be tested using analysis of variance (ANOVA). ANOVA models
utilize all available outcome data in the estimation of group
differences for individual outcomes. Due to the potential
correlation among cardiometabolic variables, a multivariate
ANOVA omnibus test will be calculated to control for
familywise type I error rate and assess patterns between multiple
dependent variables. Then, univariate ANOVA for each
dependent variable will be conducted as follow-up tests. A series
of secondary outcome variables will also be analyzed using
ANOVA models to examine group differences for a
constellation of variables (eg, sleep quality, %BF, stroke
volume, neck circumference, mean arterial pressure, etc).
Specific aim 4 is exploratory in nature. Due to the sample sizes
required to build robust multilevel models, formal hypothesis
testing will not be conducted.
Treatment of Missing Data
A multiple imputation approach will be used in the event of
missing data [89]. Under this procedure, we will use SAS
PROC.MI to complete data sets and combine these using SAS
PROC.MIANALYZE to produce final inferential results.
Sensitivity analysis will be conducted by comparing results
from only complete cases and data imputed [90]. Table 1
summarizes the hypotheses, methods of analysis, and statistical
models used for the SLUMBRx study. If the multiple imputation
computation system fails to work correctly, then nonparametric
analysis methods will be applied.
Discussion
Principal Findings
Obesity and short sleep duration are highly prevalent,
interconnected risk factors for cardiometabolic disease in adults;
however, a comprehensive adiposity-sleep model has remained
elusive because of the complexity of the relationship between
these 2 health-related states. The SLUMBRx study can help to
drive preventative public health interventions by (1) probing
the validity of the adiposity-sleep hypothesis, (2) modeling
upstream and downstream demographic and ecological factors
of adiposity and sleep, and (3) determining whether adiposity
and sleep influence cardiometabolic disease risk factors. The
proposed research will form the background of new lines of
epidemiological and experimental inquiry seeking to unpack
the relationship between adiposity, sleep, and cardiometabolic
disease. Furthermore, this study will provide data necessary to
propose and design public health interventions for obesity and
short sleep duration by identifying appropriate measures to be
used as intervention endpoints.
Conceptual Innovations
SLUMBRx is conceptually innovative in at least five ways.
First, this proposal explores the potential of adiposity indices
as modifiable risk factors for short sleep. If participants who
are overweight and obese demonstrate shorter sleep than those
who are of normal weight, it will lend credence to the hypothesis
proposed in specific aim 1 that adiposity independently and/or
interactively contributes to short sleep. Second, few studies
have used rigorous adiposity measurement when investigating
sex-based differences between sleep and adiposity as delineated
in specific aim 2. Studies that have been conducted frequently
produce conflicting or null results, suggesting that additional
research is needed to understand this phenomenon. Third, sleep,
adiposity, and cardiometabolic data will be collected
predominantly from participants in underserved, rural settings
(Tuscaloosa county in Alabama), with an anticipated high
prevalence of short sleep (<7 hours, estimated at 46.1%) and
obesity (estimated at 41.4%) [91]. Data collection in rural
settings will inform recruitment strategies for future studies.
JMIR Res Protoc 2021 | vol. 10 | iss. 3 | e27139 | p. 8https://www.researchprotocols.org/2021/3/e27139
(page number not for citation purposes)
Knowlden et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Fourth, sleep assessment will be conducted both retrospectively
(with the STQ [76], ESS [77], and PSQI [56]) and prospectively
(home sleep testing, sleep diaries, and actigraphy). Retrospective
assessment using the STQ represents one of the first uses of a
validated instrument to assess sleep schedules for identifying
short sleepers. Prospective assessment, which is rarely done, is
also important because it allows for determining whether
self-reports of short sleep are reliable over time. Fifth, the data
collected as part of specific aim 4 is innovative as research
investigating upstream and downstream socioecological drivers
of sleep is limited [20,78].
Methodological Innovations
The SLUMBRx investigation is also methodologically
innovative in several ways. First, this proposal has the potential
to drive public health intervention research by probing the
validity of the obesity-sleep hypothesis using objective sleep
and adiposity metrics. Second, the influence of sleep duration
and adiposity indices on cardiometabolic outcomes, as detailed
in specific aim 3, is a novel extension of the epidemiological
and experimental body of research. Third, this project will assess
the feasibility of public health sleep-based research undertaken
in underserved, rural communities. It is also expected that the
implementation of the protocol will inform recruitment strategies
for future grants built off this proposal. Fourth, the data collected
from this study will assist in proposing and designing future
public health interventions by identifying clinical endpoints for
sleep, adiposity, and cardiometabolic outcomes. Fifth, this study
will use a web-based data portal to provide convenient access
to study materials for participants. In addition, the data portal
will employ time stamping (assuring prospective data are indeed
prospective) and content validation of response options (eg,
restricting out-of-range responses). The system also eliminates
data entry and transcription errors that can occur when
transcribing paper-and-pencil data into electronic spreadsheets.
Conclusions
Obesity and short sleep duration in adults comprise prominent
public health concerns because of their high prevalence and
association with a wide range of harmful sequelae, including
premature mortality [92], cardiovascular disease [3], and
diabetes [93]. In recent years, there has been increased interest
in the potential link between obesity and short sleep
[11,13,26,94-96]. The proposed SLUMBRx investigation will
contribute to developing a comprehensive adiposity-sleep model
while also laying the groundwork for a future research program
that aspires to prevent and treat adiposity and sleep-associated
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